secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2024-01-11T23:59:59+00:00
Accession:  0001437749-24-001159
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key regains Nasdaq bid-price compliance after stock closes above $1.00 for 10 sessions
--------------------------------------------------------------------------------

- As of Jan 5, 2024, common stock closing bid price exceeded $1.00 for 10 consecutive business days.
- Prior deficiency notices were reported on Jan 12, 2023 and Jul 12, 2023.
- Nasdaq confirmed compliance on Jan 8, 2024, closing the matter.
- Company now meets Nasdaq Listing Rule 5550(a)(2) bid price requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774924001159/0001437749-24-001159-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774924001159/bkyi20240110_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-001159

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer